Codetta Bio
Delaware corporation · 2 known investors
Codetta Bio develops the Concerto System, a biomarker detection platform that combines digital PCR, qPCR, and immunoPCR technology to simultaneously measure proteins, DNA, and RNA from a single sample for multi-omics applications.
BiotechDeep TechMedical Devices
Founders & leadership
JM
J. Michael RamseyDirector
JC
Jacques CorriveauExecutive Officer, Director
WH
William Hampton HenleyExecutive Officer
JH
John HoDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$12.3MraisedOct 2024 · 4 investors · BiotechnologyRule 506(b)
▶$12.3MraisedOct 2024 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jacques CorriveauExecutive Officer, Director
- William Hampton HenleyExecutive Officer
- John HoDirector
- J. Michael RamseyDirector
- Offering amount
- $26.4M
- Amount sold
- $12.3M
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.